[<i>Ching Shum</i> Pills alleviates non-alcoholic fatty liver disease in mice by ameliorating lipid metabolism disorders].
CSP can improve lipid metabolism disorders in NAFLD mice through a regulatory mechanism involving multiple targets and pathways to reduce liver fat accumulation and protect liver function. The key components in CSP such as quercetin and linolenic acid monoacylglycerol may participate in the regulation of such metabolic processes as fatty acid oxidation by targeting TP53.
Authors
- Pingzheng Zhou (ORCID: https://orcid.org/0000-0002-6420-7508)
- Shiqing Zhang (ORCID: https://orcid.org/0000-0002-0785-5461)
- Bowen Luo (ORCID: https://orcid.org/0000-0003-1618-2980)
- Ken Kin Lam Yung (ORCID: https://orcid.org/0000-0002-9588-2573)
- Tong Li (ORCID: https://orcid.org/0009-0008-7522-3176)
- Xin Yi (ORCID: https://orcid.org/0000-0002-5686-2967)
- Peng Wang (ORCID: https://orcid.org/0000-0002-2549-2780)
- Yijing Cai
Institutions
- Jinan University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-09-29
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.09.04
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article